Psychedelic Psychiatry After the Renaissance

In this conversation, Dr. Kyle Greenway discusses his work in psychedelic-assisted therapy, particularly focusing on the Montreal model of ketamine therapy. He emphasizes the importance of integrating conventional psychiatry with psychedelic approaches, the role of set and setting in therapy outcomes, and the significance of music in enhancing therapeutic effects. Dr. Greenway also addresses the challenges in psychedelic research, the potential of psilocybin, and the need to consider social determinants of health in clinical trials. He reflects on the future of psychedelics in mental health treatment and the importance of navigating difficult experiences in therapy.